Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required)
What it is: A funding opportunity to let current U19 award holders add first‑in‑human genome editing clinical trials to their projects.
Program: Part of the NIH Somatic Cell Genome Editing (SCGE) program.
Key requirement: A clinical trial is required. This differs from the earlier RFA-RM-22-015, which did not require a clinical trial.
Who it’s for: Existing U19 award recip…
The NOFO aims to expand the scope of existing U19 awards to include first in human genome editing clinical trials. This opportunity is part of the NIH Somatic Cell Genome Editing program and requires a clinical trial, unlike the previous RFA-RM-22-015.
Funding Source
Eligibility
Limited competition: Eligibility is restricted to existing awardees under RFA-RM-22-015 (SCGE IND-enabling Studies of Somatic Genome Editing Therapeutic Leads) with active U19 awards. Foreign (non-U.S.) organizations are NOT eligible to apply. However, non-domestic (non-U.S.) components of U.S. …
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers